Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer

SIMPLE SUMMARY: Recurrent ovarian cancer is difficult to treat due to the development of chemotherapy resistance. This resistance develops through multiple mechanisms to include the avoidance of cell death by cancer cells. Prior studies have shown birinapant, a second mitochondrial activator of casp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Noonan, Anne M., Cousins, Amanda, Anderson, David, Zeligs, Kristen P., Bunch, Kristen, Hernandez, Lidia, Shibuya, Yusuke, Goldlust, Ian S., Guha, Rajarshi, Ferrer, Marc, Thomas, Craig J., Annunziata, Christina M.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765376/
https://ncbi.nlm.nih.gov/pubmed/33334024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123784
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky